FDA issued a Warning Letter to Mylan Pharmaceuticals Inc. on 11/9/2018 for a later inspection.
483 Mylan Pharmaceuticals Feb 2012

483 Mylan Pharmaceuticals Feb 2012

Ernest Bizjak FDA, Paula Bretz FDA, Rabin Ghoshal FDA, William Warnick FDA$119.00 - Available Now

FDA investigators audited the Mylan Pharmaceuticals - Morgantown, WV, United States facility and issued inspectional observations (via FDA 483) on 02 Feb 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 02 Feb 2012
  • Location: Morgantown, United States
  • FEI: 1110315
Add To Cart